Two Sigma Advisers’s GSK GSK Stock Holding History

Two Sigma Advisers’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-11,200	Closed	-$749K	–	2458
2014 Q2	$749K	Buy	+11,200	New	+$758K	0.01%	1368

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers's GSK Position: Q3 2024 in Review

Two Sigma Advisers sold out of GSK (GSK) in Q3 2024, closing a stake of 21,120 shares — an estimated $813K sold.

Two Sigma Advisers first reported a position in GSK in Q2 2013 and held it in 39 quarters. The position peaked at $180M in Q4 2017. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

Two Sigma Advisers reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
Two Sigma Advisers sold 21,120 GSK shares in Q3 2024, an estimated $813K.
Two Sigma Advisers first reported a position in GSK in Q2 2013 and held it in 39 quarters.
Two Sigma Advisers's GSK position peaked at $180M in Q4 2017.
899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Two Sigma Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.